TABLE 1.
Clinical factors | Training cohort (n = 44) | Clinical factors | Validation cohort (n = 57) |
---|---|---|---|
Age (years old, n, %) | — | Age (years old, n, %) | — |
≤24 | 28 (63.7%) | ≤24 | 45 (78.9%) |
>24 | 16 (36.3%) | >24 | 12 (21.1%) |
Sex (n, %) | — | Sex (n, %) | — |
Male | 2/8 (63.7%) | Male | 31 (54.4%) |
Female | 16 (36.3%) | Female | 26 (45.6%) |
Tumor status (n, %) | — | Tumor status (n, %) | — |
Localized | 32 (72.7%) | Non-metastatic | 38 (66.7%) |
Recurrence or Metastasis | 12 (27.3%) | Metastatic | 18 (31.6%) |
— | — | NA | 1 (1.7%) |